Medical Devices

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

Acarix's CADScor®System gains stringent EU MDR certification, a move poised to reshape cardiac diagnostics and fuel the company's expansion in the U.S.

A new biotech partnership is accelerating development of a once-daily tablet for hypoparathyroidism, a rare disease currently requiring injections.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

The global certification giant is betting big on ASEAN's dynamic market, moving from a license model to full control to tap into rising regulatory demands.

Eve Air Mobility secures its first major Asia-Pacific deal with AirX, setting the stage for electric air taxi services in Tokyo and Osaka by 2029.

As Telix prepares its 2025 financials, all eyes are on its blockbuster revenue, pipeline progress, and its leading role in the booming radiopharma sector.

A new bipartisan law injects vital funds into neuromuscular disease research, a victory driven by years of relentless patient advocacy. Here's what it means.

Following promising early results, RESTEM's Restem-L cell therapy enters a pivotal Phase 2/3 trial, aiming to transform treatment for IIM patients.

A new analysis of malpractice claims reveals the top drivers of patient harm in cardiology, offering critical insights to save lives and protect careers.

The EpiFaith® Smart Syringe secures landmark deals with the UK's NHS and Paris's AP-HP, signaling a new era for patient safety and market access.

After flawless human trials, a Chapel Hill startup secures funding to bring its revolutionary ultrasound-based blood clot treatment to the United States.

Gartner recognizes ETQ for its visionary QMS platform as the industry tackles supply chain risks and embraces data-driven, automated quality management.

Seven UK fire services will equip firefighters with advanced gloves from Lakeland, won in a landmark contract focusing on innovation and long-term health.

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

New Medicare rules expand access to opioid alternatives, reshaping post-surgery recovery and rewarding companies at the forefront of pain management.

Two specialized firms are joining forces, creating BlackBirchSCR to offer a new, unified model for capital raising and strategic communications.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

NextFlex's new podcast, "Electronics at the Edge," explores the flexible, lightweight tech reshaping industries from defense to healthcare.